OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
-2.88%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$123M
AUM Growth
+$123M
(-5.9%)
Cap. Flow
+$2.6M
Cap. Flow
% of AUM
2.11%
Top 10 Holdings %
Top 10 Hldgs %
99.58%
Holding
12
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
Cidara Therapeutics
CDTX
|
$5.15M |
Top Sells
| 1 |
Protara Therapeutics
TARA
|
$2.33M |
| 2 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$212K |
Sector Composition
| 1 | Healthcare | 80.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTK
1
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $40M | 32.5% | 2,600,410 | – | – |
|
|
JUNO
2
DELISTED
Juno Therapeutics, Inc.
JUNO
| $23.2M | 18.81% | 1,229,512 | – | – |
|
|
EGLT
3
DELISTED
Egalet Corporation
EGLT
| $22.1M | 17.94% | 2,889,926 | – | – |
|
4
FibroGen
FGEN
$47.8M
| $17.6M | 14.28% | 822,175 | – | – |
|
|
NBRV
5
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $6.83M | 5.54% | 1,145,890 | – | – |
|
|
6
Cidara Therapeutics
CDTX
$1.66B
| $5.15M | 4.18% | +495,050 | New | +$5.15M |
|
7
ESSA Pharma
EPIX
$11.4M
| $3.72M | 3.02% | 1,696,969 | – | – |
|
|
PVLA
8
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $2.38M | 1.93% | 1,697,384 -151,600 | -8% | -$212K |
|
9
Editas Medicine
EDIT
$231M
| $1.07M | 0.87% | 66,162 | – | – |
|
|
DRNA
10
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $644K | 0.52% | 223,457 | – | – |
|
|
CBAY
11
DELISTED
Cymabay Therapeutics
CBAY
| $522K | 0.42% | 301,477 | – | – |
|
|
12
Protara Therapeutics
TARA
$120M
| – | – | -250,000 | Closed | -$2.33M |
|